BioSpace News Archive

John Wiley & Sons, Inc., a global leader in research and education, announced an open access and subscription agreement with the Hungarian Electronic Information Service National Programme.

Axonics Modulation Technologies, Inc. announced that Michael H. Carrel has been appointed to the Axonics board of directors, effective immediately.

Authorized generic version of Humalog will be available in U.S. pharmacies at 50 percent lower list price

Opsens Inc. is pleased to announce the appointment of Mr. Alan Milinazzo as Executive Chairman of the Board of Directors.

COOLIEF* Cooled RF superior to hyaluronic acid injection in a study of knee osteoarthritis patients.

Aurora Cannabis Inc. announced that the Company has completed the acquisition of all the issued and outstanding shares of privately held Whistler Medical Marijuana Corporation, in an all-share transaction, pursuant to the terms of an amalgamation agreement dated January 31, 2019 among Whistler, Aurora, and a wholly owned subsidiary of Aurora.

RecalMax™ is the Twelfth Innovus Pharma Product Approved in Canada to Date

Acerus Pharmaceuticals Corporation announced that it has filed a New Drug Submission for Avanafil with Health Canada.

Ra Pharmaceuticals, Inc. announced that Doug Treco, Ph.D., President and Chief Executive Officer of Ra Pharma, will present at the Cowen 39th Annual Health Care Conference on Monday, March 11, 2019 at 1:30 p.m. E.T. The conference is being held at Boston Marriott Copley Place, Boston, MA.

Increasing GENOVAC platform capacity and antibody development services necessary to meet demand